Core Viewpoint - AstroNova is engaging with investors to discuss its recent earnings release and performance outlook [2][3]. Group 1: Company Overview - The conference call is led by Deborah Pawlowski, with participation from the CEO Jorik Ittmann and CFO Tom DeByle [3]. - The earnings release and accompanying slides are available on the company's Investor Relations website [3]. Group 2: Financial Performance - Management will discuss forward-looking statements regarding the company's plans and expectations, which are subject to various risks and uncertainties [4]. - Non-GAAP financial measures will be referenced to provide additional insights into the company's performance [5].

Core Viewpoint - Ingevity is conducting a Strategic Portfolio update to discuss future events and financial performance, emphasizing the importance of non-GAAP financial measures in their analysis [2][3]. Group 1: Presentation Overview - The presentation is led by John Nypaver, the VP of Investor Relations and Treasurer, who welcomes attendees to the update [1]. - The discussion will include insights from key executives: Dave Li (CEO), Mary Hall (CFO), and Phil Platt (incoming CFO and current SVP of Finance) [4]. Group 2: Financial Measures - The company will refer to non-GAAP financial measures during the presentation, which are intended to supplement GAAP measures [2]. - Definitions and reconciliations of these non-GAAP measures are available in the appendix of the slide deck and the most recent Form 10-K [2]. Group 3: Forward-Looking Statements - The presentation will include forward-looking statements regarding the company's future events and financial performance, with a caution that actual results may differ from projections [3].

CHAGEE (NASDAQ: CHA) 2025Q3 Earnings Presentation ovember 28, 2025 DISCLAIMER This presentation contains forvardel-coking statements with n the nearing of Section 21E of the U.S. Securilies Echançe Ad of 1934, as ameded. These forward-couling state Prinzan Securites: Libgrain Reform Ao of 1955. These stalenents car be identified by relemint on your as "mill", "epents," antipraels," fritans," plans," Belenes," estimat ands sin ila state nems. Chage nay also make written or raal forward-looking statenents in ...

Core Viewpoint - BingEx Limited, operating under the brand "FlashEx," reported a decline in revenues and order volume for Q3 2025, primarily due to intensified market competition, while also highlighting efforts to enhance brand reputation and customer loyalty [1][3][4]. Financial Performance - Revenues for Q3 2025 were RMB1,005.4 million (US$141.2 million), down from RMB1,154.8 million in Q3 2024, reflecting a decrease of approximately 12.9% [4][6]. - Cost of revenues decreased to RMB893.6 million (US$125.5 million) from RMB1,024.5 million in the same period of 2024, aligning with the revenue decline [4][6]. - Gross profit was RMB111.8 million (US$15.7 million), compared to RMB130.3 million in Q3 2024, with a gross profit margin of 11.1%, slightly down from 11.3% [5][6]. - Operating income fell to RMB14.1 million (US$2.0 million) from RMB46.2 million in Q3 2024, while non-GAAP operating income was RMB23.7 million (US$3.3 million) [6][8]. - Net income increased to RMB43.7 million (US$6.1 million) from RMB23.8 million in the same period of 2024, with non-GAAP net income rising to RMB62.6 million (US$8.8 million) from RMB57.6 million [10][11]. Shareholder Value - Shareholders' equity grew from RMB747.1 million at the end of 2024 to RMB839.3 million as of September 30, 2025 [3][10]. - The company repurchased approximately 1.6 million American Depositary Shares (ADSs) for about US$5.4 million as part of its share repurchase program [3][12]. Operational Insights - The number of orders fulfilled in Q3 2025 was 63.2 million [6]. - General and administrative expenses increased by 105.2% to RMB37.0 million (US$5.2 million) due to higher professional fees and share-based compensation [7]. - Research and development expenses decreased by 20.1% to RMB17.7 million (US$2.5 million) [8]. Market Positioning - The company emphasized its commitment to enhancing competitiveness and expanding service categories to meet evolving user needs, aiming for sustainable growth while fulfilling social responsibilities [3][15].

INVESTOR DAY November 13th, 2025 Disclaimers Forward-Looking Statements This presentation contains forward-looking information and statements, within the meaning of applicable securities laws (collectively, "forward-looking statements"), including, but not limited to, statements regarding future prospects and performance of Bausch + Lomb Corporation ("Bausch + Lomb", the "Company", "we", "us", or "B+L"), our 2025 full year guidance, our three year financial targets (including targets for Company and segment ...

Financial Data and Key Metrics Changes - Consolidated total revenue for Q3 2025 was $347.1 million, an increase of 43.3% compared to $242.2 million in the prior year period [16] - Net loss attributable to common stockholders decreased to $9.4 million, or $0.71 per fully diluted share, compared to $15.3 million, or $1.18 per fully diluted share in the prior year [16] - Total adjusted EBITDA was $19.8 million in Q3 2025, up from $16.8 million in the prior year period [16][17] Business Line Data and Key Metrics Changes - Infrastructure segment revenue increased by 45.4% to $338.4 million from $232.8 million in the prior year quarter, driven by project timing and size at DBM Global [17] - DBM Global achieved adjusted EBITDA of $23.5 million, up from $20.9 million in the prior year [18] - Life sciences revenue increased by 3.3% to $3.1 million, primarily driven by R2's sales growth [19][20] - Spectrum segment revenue decreased by $800,000 to $5.6 million, with adjusted EBITDA down by $700,000 to $1 million [21] Market Data and Key Metrics Changes - DBM Global's adjusted backlog increased by approximately $500 million to just over $1.6 billion since the end of 2024 [7] - R2's year-to-date revenues increased by approximately 65% over the same period from last year, with significant growth in international markets [11] - Spectrum faced a challenging advertising environment, but new network launches are showing signs of strength in Q4 [15] Company Strategy and Development Direction - The company is exploring strategic alternatives for DBM Global and HC2 Broadcasting, indicating a focus on optimizing asset value [5] - There is a commitment to exiting life science businesses, although this process has taken longer than expected [5] - The company is focused on enhancing its infrastructure and data center capabilities, anticipating growth in these areas [9] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the momentum building for 2026, driven by a growing adjusted backlog and improving market conditions [9] - The approval of MediBeacon's Lumitrace injection is expected to unlock access to a significant healthcare market in China [10] - Management noted that while EBITDA may come in slightly below 2024 levels, there is confidence in the growth trajectory for the infrastructure segment [9] Other Important Information - As of September 30, 2025, the company reported a backlog of $1.5 billion and an adjusted backlog of $1.6 billion [19] - The company had total principal outstanding indebtedness of $700.4 million, an increase from $668.3 million at the end of 2024 [23] Q&A Session Summary - There were no questions during the Q&A session, indicating a lack of immediate inquiries from analysts or investors [24]

Core Insights - LandBridge Company LLC reported a strong financial performance for Q3 2025, achieving a revenue growth of 78% year-over-year and 7% quarter-over-quarter, marking the sixth consecutive quarter of revenue and Adjusted EBITDA growth [1][5][9] - The company declared a quarterly cash dividend of $0.10 per share, reflecting its commitment to returning value to shareholders [1][20] - LandBridge completed the acquisition of approximately 37,500 acres, increasing its total holdings to over 300,000 surface acres, which supports its strategy of optimizing and diversifying revenue streams [1][6][8] Financial Performance - Revenues for Q3 2025 were $50.8 million, compared to $28.5 million in Q3 2024, with a net income of $20.3 million and a net income margin of 40% [5][9][11] - Adjusted EBITDA reached $44.9 million, up 79% year-over-year, with an Adjusted EBITDA margin of 88% [5][10][11] - Free Cash Flow for Q3 2025 was $33.7 million, reflecting a Free Cash Flow margin of 66% [5][16][41] Revenue Streams - Surface Use Royalties and Revenue generated $35.0 million in Q3 2025, up from $16.5 million in Q3 2024, driven by increased commercial activity [12] - Resource Sales and Royalties contributed $10.8 million, showing a 2% sequential increase [13] - Oil and Gas Royalties increased by 22% sequentially to $3.3 million, supported by higher net royalty production [14] Recent Developments - The acquisition of 37,500 acres enhances LandBridge's capacity to meet rising demand for high-quality pore space and supports potential alternative energy developments [6][8] - The company finalized the sale of a 3,000-acre solar energy generation project, which has a proposed capacity of up to 250 MW, indicating a strategic move towards alternative energy [7][45] Outlook - LandBridge reaffirms its fiscal year 2025 outlook, expecting Adjusted EBITDA to be between $165 million and $175 million [21]

Core Viewpoint - Katapult Holdings held its Third Quarter 2025 Earnings Call, discussing financial performance and future guidance [2]. Group 1: Financial Performance - The call included remarks from key executives, including the CEO, CFO, and Chief Growth Officer, indicating a focus on operational results and financial guidance [2]. - The company provided both GAAP and non-GAAP financial measures, emphasizing the importance of understanding these metrics in evaluating performance [3]. Group 2: Forward-Looking Statements - The executives made forward-looking statements regarding financial guidance and business operations, highlighting the inherent risks and uncertainties associated with these projections [3]. - The company noted that actual results may differ materially from these forward-looking statements, which are based on current beliefs and assumptions [3].

Core Insights - Assertio Holdings reported strong financial results for Q3 2025, with significant growth in net product sales, particularly for Rolvedon, which saw sales increase to $38.6 million from $15.0 million year-over-year [7][2] - The company has narrowed its FY2025 net product sales guidance to a range of $110 million to $112 million and adjusted EBITDA guidance to $14 million to $16 million [5][1] - Paul Schwichtenberg has been promoted to President and COO, indicating a strategic focus on operational efficiency and commercial execution [6][8] Financial Performance - Rolvedon net product sales reached $38.6 million in Q3 2025, a 157% increase from $15.0 million in Q3 2024 [7] - Sympazan net product sales grew to $2.8 million in Q3 2025, up from $2.6 million in the prior-year quarter [7] - Indocin net product sales decreased to $4.8 million in Q3 2025 from $5.7 million in Q3 2024 due to generic competition [7] - Gross margin was reported at 72%, down from 74% in the prior-year quarter, attributed to a higher proportion of Rolvedon sales [7] - Adjusted EBITDA for Q3 2025 was $20.9 million, significantly up from $4.4 million in Q3 2024 [7] Guidance and Outlook - The updated guidance for FY2025 reflects the impact of the Rolvedon pull-forward and improved visibility into expected performance for the remainder of the year [5][2] - The company expects uninterrupted patient supply of Rolvedon, with regular sales of the newly labeled product anticipated to begin in Q2 2026 [7] Leadership Changes - Paul Schwichtenberg's promotion to President and COO is aimed at enhancing commercial strategies and driving future growth [8][6] - Schwichtenberg has a history of leadership roles within the company, focusing on operational and commercial execution [8]

Core Insights - Aeries Technology held its Second Quarter Fiscal 2026 Earnings Conference Call to discuss results for the quarter ended September 30, 2025, and outline strategic priorities for future growth [1]. Financial Performance - The call included discussions on Aeries' expectations regarding future performance and market opportunities, indicating a focus on growth and strategic direction [2]. Strategic Priorities - The leadership team, including CEO Ajay Khare and CFO Daniel Webb, is set to review the company's strategic priorities that will shape the next stage of growth [1].